Israel has had a robust and solid medical cannabis program for more than 30 years, a strong R&D and innovation center and a large percentage of adult usage, yet recreational…
COVID-19 Impact In the first half of 2020, CBD companies are experiencing a loss in revenue due to store closures and consumer concerns about Coronavirus and their finances. Shelter-at-home policies…
I am a pharmacist. When I studied pharmaceutical science at Sydney University 24 years ago we were not taught about the Endocannabinoid System (ECS). We were not taught that the…
When I was at Pharmacy School at Sydney University, more than 20 years ago, we learned the pharmaceutical and clinical sciences ranging from the design, synthesis, formulation, dispensing and testing…
What a stressful time this is for all of us. People across the globe have been affected by a new, severe, physical illness making the headlines. Perhaps the constant daily…
Cannabis Investing in a Coronavirus World 60 days ago, cannabis investors were excited about 2020. More states and countries legalized, supply chains were ready, and customer demand was growing…
Capitalizing on cannabis is occurring across the Western hemisphere. From North America down to South America, there is a trail of expansion, investment, mergers, and acquisitions.
Entrepreneurship is essentially about problem solving; finding a gap in the market, an area yet untapped, a new way to do something - and building a business from there. We’d…
Our London Pitch event was exciting. The energy was high, the audience enthused and our expert panel of judges rocked it! We had an impressive bunch of investors who served as our…
We are so excited to introduce you all to JP, otherwise know as John-Paul, CEO and Co-founder of GrowX. We had the pleasure of meeting JP at this year’s CannaTech…
